Valentina Ambrosini

Summary

Affiliation: University of Bologna
Country: Italy

Publications

  1. ncbi (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study
    Valentina Ambrosini
    Department of Nuclear Medicine, Sant Orsola Malpighi University Hospital, Bologna, Italy
    Clin Nucl Med 38:e171-7. 2013
  2. ncbi Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?
    Valentina Ambrosini
    Nuclear Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Eur J Nucl Med Mol Imaging 39:1278-83. 2012
  3. ncbi ⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET
    Valentina Ambrosini
    Nuclear Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Eur J Nucl Med Mol Imaging 39:S52-60. 2012
  4. ncbi F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease
    Valentina Ambrosini
    Department of Nuclear Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Clin Nucl Med 37:196-7. 2012
  5. ncbi 68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease
    Valentina Ambrosini
    Departments of Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, S Orsola Malpighi University Hospital, Bologna, Italy
    Clin Nucl Med 36:64-5. 2011
  6. ncbi 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors
    Valentina Ambrosini
    Department of Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, S Orsola Malpighi University Hospital, Bologna, Italy
    J Nucl Med 51:669-73. 2010
  7. ncbi 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results
    Valentina Ambrosini
    Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, S Orsola Malpighi Hospital, Bologna, Italy
    J Nucl Med 51:1950-5. 2010
  8. ncbi Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
    Valentina Ambrosini
    Unità Operativa di Medicina Nucleare, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Padiglione 30, Via Massarenti 9, 40138, Bologna, Italy
    Eur J Nucl Med Mol Imaging 35:1431-8. 2008
  9. ncbi (68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours
    Valentina Ambrosini
    Department of Nuclear Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Eur J Nucl Med Mol Imaging 37:722-7. 2010
  10. ncbi Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours
    Valentina Ambrosini
    Unità Operativa di Medicina Nucleare, Policlinico S Orsola Malpighi, Bologna, Italy
    Nucl Med Commun 28:473-7. 2007

Collaborators

Detail Information

Publications48

  1. ncbi (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study
    Valentina Ambrosini
    Department of Nuclear Medicine, Sant Orsola Malpighi University Hospital, Bologna, Italy
    Clin Nucl Med 38:e171-7. 2013
    ..Secondary aim was to investigate the changes in cardiac FDG uptake related to the specific preparation before PET/CT...
  2. ncbi Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?
    Valentina Ambrosini
    Nuclear Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Eur J Nucl Med Mol Imaging 39:1278-83. 2012
    ..The aim of the study is to evaluate the potential usefulness of (68)Ga-DOTA-NOC PET/CT in patients with suspected NET...
  3. ncbi ⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET
    Valentina Ambrosini
    Nuclear Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Eur J Nucl Med Mol Imaging 39:S52-60. 2012
    ....
  4. ncbi F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease
    Valentina Ambrosini
    Department of Nuclear Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Clin Nucl Med 37:196-7. 2012
    ..Chronic steroid and hormone replacement therapy was administered, and the patient was asymptomatic. F-18 FDG PET/CT was useful for disease restaging at cardiac and soft tissues level...
  5. ncbi 68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease
    Valentina Ambrosini
    Departments of Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, S Orsola Malpighi University Hospital, Bologna, Italy
    Clin Nucl Med 36:64-5. 2011
    ....
  6. ncbi 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors
    Valentina Ambrosini
    Department of Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, S Orsola Malpighi University Hospital, Bologna, Italy
    J Nucl Med 51:669-73. 2010
    ..The aim of this study was to assess the impact of (68)Ga-DOTANOC PET/CT on the clinical management of NET patients...
  7. ncbi 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results
    Valentina Ambrosini
    Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, S Orsola Malpighi Hospital, Bologna, Italy
    J Nucl Med 51:1950-5. 2010
    ..The aim of this study was to evaluate (68)Ga-DOTANOC PET/CT in patients with IPF and NSIP...
  8. ncbi Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
    Valentina Ambrosini
    Unità Operativa di Medicina Nucleare, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Padiglione 30, Via Massarenti 9, 40138, Bologna, Italy
    Eur J Nucl Med Mol Imaging 35:1431-8. 2008
    ..At present, there are no comparative studies investigating their role in NET...
  9. ncbi (68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours
    Valentina Ambrosini
    Department of Nuclear Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Eur J Nucl Med Mol Imaging 37:722-7. 2010
    ..To retrospectively evaluate the sensitivity, specificity and accuracy of (68)Ga-DOTA-NOC PET/CT and CT alone for the evaluation of bone metastasis in patients with neuroendocrine tumour (NET)...
  10. ncbi Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours
    Valentina Ambrosini
    Unità Operativa di Medicina Nucleare, Policlinico S Orsola Malpighi, Bologna, Italy
    Nucl Med Commun 28:473-7. 2007
    ....
  11. ncbi 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid
    Valentina Ambrosini
    Department of Nuclear Medicine, Policlinico S Orsola Malpighi Hospital, Bologna, Italy
    Nucl Med Commun 30:281-6. 2009
    ..However, their role in BC has never been evaluated. Our aim is to evaluate the role of 68Ga-DOTA-NOC (68Ga-labelled [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-1-Nal3-octreotide) PET for the assessment of BC patients...
  12. ncbi Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET
    Stefano Fanti
    Unità Operativa di Medicina Nucleare, Policlinico S Orsola Malpighi, Bologna, Italy
    Biomed Pharmacother 62:667-71. 2008
    ..On the other hand, care has to be paid when studying lesions localized at sites of physiological concentration of the tracer, and in presence of inflammation...
  13. ncbi 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma
    Cristina Nanni
    Nuclear Medicine, PET Unit, Policlinico S Orsola Malpighi, Bologna University, Italy
    World J Surg Oncol 5:68. 2007
    ..Whole body skeletal survey (WBSS), Magnetic resonance (MR) and 18F-FDG PET/CT are imaging techniques routinely used for the evaluation of bone involvement in MM patients...
  14. ncbi Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma
    Anna Margherita Maffione
    Unità Operativa di Medicina Nucleare, Policlinico S Orsola Malpighi, Bologna, Italy
    Clin Nucl Med 34:777-8. 2009
    ..This case indicates that after completion of radioimmunotherapy it may be recommended to wait several weeks before performing a PET scan and, in case of minimal findings, to consider a short-term re-evaluation...
  15. ncbi 68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results
    Cristina Nanni
    Medicina Nucleare, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    J Nucl Med 51:1932-6. 2010
    ..The aim of this work was to preliminarily evaluate the sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy of (68)Ga-citrate PET/CT in a population of patients with suspected bone infections...
  16. ncbi Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET
    Valentina Ambrosini
    Nuclear Medicine Department, Policlinico S Orsola Malpighi, Bologna University, Italy
    Nucl Med Commun 28:647-52. 2007
    ..There are various murine models for human lung adenocarcinoma, but those for squamous cell lung carcinoma, the most common form of human cancer, are lacking...
  17. ncbi Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?
    Paolo Castellucci
    Service of Nuclear Medicine, Department of Haematology Oncology and Laboratory Medicine, Azienda Ospedaliero Universitaria di Bologna, Policlinico Sant Orsola Malpighi, University of Bologna, Bologna, Italy
    Eur J Nucl Med Mol Imaging 38:55-63. 2011
    ..5 ng/ml (early biochemical relapse) during follow-up (FU)...
  18. ncbi Incidence of increased 68Ga-DOTANOC uptake in the pancreatic head in a large series of extrapancreatic NET patients studied with sequential PET/CT
    Paolo Castellucci
    Nuclear Medicine Unit, Hematology Oncology and Laboratory Medicine Department, Azienda Ospedaliero Universitaria di Bologna Policlinico S Orsola Malpighi, University of Bologna, Bologna, Italy
    J Nucl Med 52:886-90. 2011
    ....
  19. ncbi Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma
    Pier Luigi Zinzani
    Institute of Hematology and Oncology L and A Seragnoli, University of Bologna, Bologna, Italy
    J Clin Oncol 27:1781-7. 2009
    ..However, there are no prospective studies investigating the value of serial FDG-PET over time in patients in complete remission...
  20. ncbi PET/CT with 68Gallium-DOTA-peptides in NET: an overview
    Valentina Ambrosini
    Department of Nuclear Medicine, Sant Orsola Malpighi University Hospital, Bologna, Italy
    Eur J Radiol 80:e116-9. 2011
    ....
  21. ncbi Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings
    Mohsen Farsad
    UO Medicina Nucleare, , Policlinico S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    Nucl Med Commun 26:827-30. 2005
    ..The only common feature to all was the paravenous injection of the radiotracer. CONCLUSION: The lesions detected by PET may be related to distal lung microembolism originating from the site of paravenous injection...
  22. ncbi Additional value of hybrid PET/CT fusion imaging vs. conventional CT scan alone in the staging and management of patients with malignant pleural mesothelioma
    Valentina Ambrosini
    Nuclear Medicine Service - PET Unit, Policlinico S. Orsola-Malpighi, Bologna University, Bologna, Italy
    Nucl Med Rev Cent East Eur 8:111-5. 2005
    ..3% of cases). CONCLUSIONS: Our data show that (18)F-FDG PET/CT fusion imaging can play a relevant role in the staging and treatment planning of MPM patients...
  23. ncbi (18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging
    Egesta Lopci
    Department of Nuclear Medicine, Policlinico S Orsola Malpighi, Bologna, Italy
    Cancer Biother Radiopharm 23:681-90. 2008
    ..4% specificity for CI. This comparative study shows FDG PET to be more accurate than CI in evaluating children with lymphoma. Our data also confirms that (18)F-FDG PET may show false-positive findings...
  24. ncbi 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone
    Cristina Nanni
    Department of Nuclear Medicine, Policlinico S Orsola Malpighi, Bologna, Italy
    In Vivo 22:513-7. 2008
    ..To evaluate the value of 18F-fluorodeoxy-glucose (FDG) positron emission tomography with computed tomography (PET/CT) in myeloma in patients presenting with a solitary plasmacytoma of bone (SPB)...
  25. ncbi Small animal PET in oncology: the road from bench to bedside
    Valentina Ambrosini
    Department of Nuclear Medicine, Policlinico S Orsola Malpighi, Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy
    Cancer Biother Radiopharm 24:277-85. 2009
    ..This review focuses on the applications of SA-PET for the visualization of the pathophysiologic pathways of tumor cells...
  26. ncbi Diagnostic role of 18F-FDG PET in gastric MALT lymphoma
    Valentina Ambrosini
    Department of Nuclear Medicine - PET Unit, Policlinico S. Orsola-Malpighi Hospital, Bologna, Italy
    Nucl Med Rev Cent East Eur 9:37-40. 2006
    ..CONCLUSION: Our data demonstrate the significant accuracy of 18F-FDG-PET in detecting active disease in gastric lymphoma of both MALT and non-MALT NHL type. A higher SUV value appears to be related to a more aggressive disease...
  27. ncbi Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET
    Stefano Fanti
    Unità Operativa di Medicina Nucleare, Padiglione 30, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    Ann Nucl Med 22:429-32. 2008
    ..This case testifies the possibility of early relapse of lymphoma even in the case of negative interim PET; it also supports the usefulness of end-treatment PET scan in lymphoma patients...
  28. ncbi Small animal PET for the evaluation of an animal model of genital infection
    Cristina Nanni
    Department of Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    Clin Physiol Funct Imaging 29:187-92. 2009
    ..Since the 1970s, Gallium scintigraphy is a well established test that has been used for the evaluation of inflammation and infection in human patients...
  29. ncbi FDG small animal PET permits early detection of malignant cells in a xenograft murine model
    Cristina Nanni
    Nuclear Medicine, Azienda Ospedaliera di Bologna Policlinico S Orsola Malpighi, Bologna, Italy
    Eur J Nucl Med Mol Imaging 34:755-62. 2007
    ..A second goal was to analyse the metabolic behaviour of this xenograft tumour over time...
  30. ncbi (11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy
    Francesco Ceci
    Nuclear Medicine Unit, Department of Haematology Oncology and Laboratory Medicine, Azienda Ospedaliero Universitaria di Bologna, Policlinico Sant Orsola Malpighi, University of Bologna, Bologna, Italy
    Eur J Nucl Med Mol Imaging 40:149-55. 2013
    ....
  31. ncbi 68Ga DOTANOC PET/CT detects medullary thyroid cancer relapse at bone level
    Silvia Nicolini
    Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, S Orsola Malpighi University Hospital, Bologna, Italy
    Clin Nucl Med 37:591-2. 2012
    ..This case shows that PET/CT with DOTANOC may be a useful complementary imaging modality in patients with well-differentiated MTC...
  32. ncbi PET/CT imaging in different types of lung cancer: an overview
    Valentina Ambrosini
    Department of Nuclear Medicine, Sant Orsola Malpighi Hospital, Bologna, Italy
    Eur J Radiol 81:988-1001. 2012
    ....
  33. ncbi Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors
    Davide Campana
    Department of Clinical Medicine, Policlinico S Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    J Nucl Med 51:353-9. 2010
    ..Therefore, we prospectively investigated whether (68)Ga-[1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-1-NaI3-octreotide ((68)Ga-DOTANOC) PET SUVmax could be used as an accurate noninvasive marker for disease prognosis...
  34. ncbi Positron-emission tomography in gynaecologic malignancies
    Anna Margherita Maffione
    Department of Nuclear Medicine, Policlinico S Orsola Malpighi, Bologna, Italy
    Arch Gynecol Obstet 280:521-8. 2009
    ..However, this under utilisation is being actively re-addressed with a large number of reviews and studies, particularly in the last few years...
  35. ncbi Molecular imaging of neuroblastoma progression in TH-MYCN transgenic mice
    Carmelo Quarta
    Department of Nuclear Medicine, S Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    Mol Imaging Biol 15:194-202. 2013
    ..The aim of our study was to assess the potential of small animal positron emission tomography (SA-PET) to study neuroblastoma progression in TH-MYCN mice...
  36. ncbi FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis
    Cristina Nanni
    Unit of Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna Policlinico S Orsola Malpighi, Via Massarenti n 9, 40141, Bologna, Italy
    Eur J Nucl Med Mol Imaging 39:1538-44. 2012
    ..The aim of the study was to assess the possible role of FDG PET/CT for the early evaluation of response to therapy in patients affected by infective discitis, in comparison to C-reactive protein (CRP) serum levels...
  37. ncbi The value of 18F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients
    Cristina Nanni
    Department of Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    Clin Nucl Med 38:e74-9. 2013
    ..The objective of this study was to analyze the prognostic value of (18)F-FDG PET/CT after therapy in patients with multiple myeloma (MM)...
  38. ncbi The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients
    Cristina Nanni
    Department of Nuclear Medicine, Policlinico Sant Orsola Malpighi, Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy
    Biomed Pharmacother 67:172-8. 2013
    ..The aim of this study was to evaluate the impact of the contemporary execution of both the techniques employing a PET/CT scanner on the conclusiveness of the final report. Secondary aim was to verify the concordance of the two reports...
  39. ncbi Radiopeptide imaging and therapy in Europe
    Valentina Ambrosini
    Nuclear Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    J Nucl Med 52:42S-55S. 2011
    ..Finally, another peptide family, the arginine-glycine-aspartate-based radiotracers, has made it to the clinic labeled with a variety of radioisotopes for monitoring the integrins α(v)β(3) overexpressed during tumor angiogenesis...
  40. ncbi Alveolar Rhabdomyosarcoma With Neuroendocrine Differentiation Detected by Ga-68 DOTA-NOC PET/CT: A Case Report
    Lucia Zanoni
    From the PET Center, Department of Nuclear Medicine, University Hospital S Orsola Malpighi, Bologna, Italy and Radiopharmacy, Department of Nuclear Medicine, University Hospital S Orsola Malpighi, Bologna, Italy
    Clin Nucl Med 36:915-8. 2011
    ..Ga-68 DOTA-NOC PET/CT demonstrated multiple lesions in her axilla, thoracic spine, and retroperitoneum. Biopsy of a palpable nodule at her left forearm revealed alveolar rhabdomyosarcoma with neuroendocrine differentiation...
  41. ncbi Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy
    Roberto Tonelli
    Department of Pediatric Hematology, University of Bologna, Bologna, Italy
    Clin Cancer Res 18:796-807. 2012
    ..Our aim was to determine the prevalence of N-Myc protein expression and the potential therapeutic effects of reducing expression in rhabdomyosarcomas, including use of an antigene strategy that inhibits transcription...
  42. ncbi 68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients
    Valentina Ambrosini
    Nucl Med Commun 29:415-7. 2008
  43. ncbi 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma
    Lapo Alinari
    Institute of Hematology and Oncology Seragnoli, University of Bologna, Italy
    Leuk Lymphoma 47:2096-101. 2006
    ..Sensitivity of 18F FDG-PET for extra-nodal MALT was 81%. The data show that 18FDG-PET is a useful diagnostic tool in order to stage, restage or monitor disease in patients with extra-nodal MALT lymphoma...
  44. ncbi Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies
    Cristina Nanni
    Nuclear Medicine Department, Azienda Ospedaliero Universitaria di Bologna Policlinico S Orsola Malpighi, Italy
    Nucl Med Commun 28:547-53. 2007
    ..The aim of our study was to compare the retro-orbital (RO) versus tail vein intravenous (i.v.) administration of (18)F-FDG and (11)C-choline in mice for small-animal PET studies...
  45. ncbi Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer
    Cristina Nanni
    Department of Radiology, Istituto Oncologico Veneto (IOV, Padova, Italy
    Biomed Pharmacother 60:409-13. 2006
    ....
  46. ncbi Discordant response to chemotherapy: an unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients
    Lapo Alinari
    , Italy
    Leuk Lymphoma 47:1048-52. 2006
    ....
  47. ncbi Is there an ideal diagnostic algorithm in solitary pulmonary nodules?
    Valentina Ambrosini
    Respiration 73:587-9. 2006
  48. ncbi Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism
    Mirco Galiè
    Dipartimento Scienze Morfologico Biomediche, sez Anatomia ed Istologia, Universita di Verona, Verona, Italy
    Neoplasia 9:900-8. 2007
    ..Our results suggests that FDG-PET-based clinical analysis can underestimate the malignity or tumor extension of carcinomas exhibiting any trait of "mesenchymalization" such as desmoplasia or epithelial-mesenchymal transition...